Board Committees and Charters
Baxter’s Board of Directors has established standing committees to provide oversight across critical focus areas, including audit, compensation and human capital, quality and regulatory compliance, and nominating, corporate governance and public policy. Each committee operates under a formal charter that outlines its purpose, organization and responsibilities.
Board of Directors
Baxter’s Board provides oversight of the company’s governance framework. Each committee is currently composed of solely independent directors and is governed by a written charter.
Board Committees and Charters
Below is a summary of each committee’s purpose. Each committee’s charter is available as PDFs at the links below for more detailed information on structure, organization and responsibilities.
Audit Committee
Concerned with the integrity of our financial statements, system of internal accounting controls, the internal and external audit process and the process for monitoring compliance with laws and regulations as it relates to financial matters.
Members of the Audit Committee:
Compensation and Human Capital Committee
Exercises the authority of the Board relating to employee benefit, compensation and equity-based plans of the company's executives and overseeing the development, implementation and effectiveness of the company’s policies and strategies relating to human capital management.
Members of the Compensation and Human Capital Committee:
Nominating, Corporate Governance and Public Policy Committee
Advises the Board on director nominations, corporate governance, general Board organization and planning matters, and on current and emerging political, corporate citizenship and public policy issues that may affect Baxter's business operations, performance or public image.
Members of the Nominating, Corporate Governance and Public Policy Committee:
- Patricia B. Morrison (Chair)
- Brent Shafer
- David S. Wilkes, M.D.
Quality and Regulatory Compliance Committee
Oversight responsibility with respect to quality and medical affairs and certain other quality and regulatory compliance matters, including with respect to quality and regulatory aspects of the company’s research and development programs.
Members of the Quality and Regulatory Compliance Committee:
